- Brooks Laboratories Ltd
- BROOKS (NSE)
Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company working on a contract basis. The Company operates through the Pharmaceuticals segment. It manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup and eye/ear drops. Its products under Carbapenem category includes Imipenem 250mg + Cilastatin 250mg, Imipenem 500mg + Cilastatin 500mg, Meropenem 125mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg, Meropenem 1000mg+Sulbactam 500mg, Meropenem 1000mg+Tazobactam 500mg, Doripenem 500mg and Doripenem 1000mg. It offers Penicillins in the form of injections, tablets and dry syrup. Its General category of products include liquid injections, dry powder injections and eye/ear drops. The Company has two manufacturing plants, which are located at Baddi in Himachal Pradesh and Vadodara in Gujarat. The Company manufactures and markets the pharmaceuticals nationally and internationally to various regulated markets.
Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.